March 21st 2025
Sesh Sundararaman, MD, PhD, discusses his findings and how this approach can be triggered to minimize undesirable treatment features and open the door to newer treatment possibilities.
Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care
View More
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
Addressing Racial Disparities in Multiple Myeloma: Forging a Path Towards Health Equity in Clinical Trials and Everyday Practice
View More
First Doses of R21/Matrix-M Malaria Vaccine Administered in Ivory Coast
July 19th 2024With an efficacy rate of 78% and WHO prequalification, the vaccine rollout aims to vaccinate 6.6 million children across 15 African countries by the end of 2024, marking an advancement in public health efforts to combat malaria's impact
Read More
The CDC’s Rapid Detection Assays on Combating the Spread of Anopheles stephensi
July 10th 2024Christina Rafferty, BSc, an expert from the CDC, discusses the CLASS assay for swift and accurate detection of Anopheles stephensi, which is essential for controlling malaria spread and protecting communities from resurgence in Africa.
Read More
Avian Influenza in Dairy Cattle: Implications for Milk Production and Biosecurity
July 2nd 2024Recent studies in Emerging Infectious Diseases have highlighted the persistence of highly pathogenic avian influenza A (H5N1) virus on milking equipment surfaces and its presence in dairy cattle mammary glands.
Read More
The R21/Matrix-M Vaccine: A Breakthrough in Malaria Eradication Efforts
April 25th 2024In a collaboration between the University of Oxford, the Ministry of Health in Rwanda, and the Rwanda Biomedical Centre, groundbreaking data on the R21/Matrix-M malaria vaccine, marks a significant shift in the malaria paradigm.
Read More